基本信息
views: 866
Career Trajectory
Bio
James leads on Urology research, encompassing NIHR Clinical Lecturers, NIHR ACFs, post-docs, technicians, research nurses and PhD students. The team research the translational application of molecular biology to urological malignancies, in particular Bladder and Prostate Cancer, and partake in clinical trials focused on improving the care of patients with these cancers. James's particular interest is in the epigenetic alterations seen within these tumours.
Research Interests
Papers共 566 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 13 (2024): 1466-1471
JOURNAL OF CLINICAL PATHOLOGYno. 5 (2024): 291-296
James WF Catto, Syed A Hussain,Ben Tran,Geraldine Pignot,Viraj Master, Morgan Rouprêt,Andrea Tubaro, Nobuaki Shimizu,Nikhil Vasdev, Hiroyuki Nishiyama, Siamak Daneshmand,Yuji Miura,
Urologic Oncology: Seminars and Original Investigations (2024)
Jon Griffin,Jenny Down,Lewis A. Quayle, Paul R. Heath,Ewan A. Gibb,Elai Davicioni, Yang Liu,Xin Zhao,Jayne Swain,Dennis Wang,Syed Hussain,Simon Crabb,
JOURNAL OF PATHOLOGY CLINICAL RESEARCHno. 2 (2024): n/a-n/a
Zoe Rogers,Adam Glaser,James W. F. Catto,Sarah Bottomley,Ibrahim Jubber,Sanjeev Kotwal, Paul Brittain, Jonathan Gill, Mark A. Rogers,Mohantha D. Dooldeniya,Philip Koenig,Jo Cresswell,
BJU INTERNATIONALno. 4 (2024): 460-473
European Urology (2024)
ANNALS OF ONCOLOGYno. 1 (2024): 98-106
European Urology Oncology (2023)
NEJM evidenceno. 4 (2023): EVIDoa2300018-EVIDoa2300018
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn